Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dazodalibep by Amgen for Sicca Syndrome (Sjogren): Likelihood of Approval
Dazodalibep is under clinical development by Amgen and currently in Phase III for Sicca Syndrome (Sjogren). According to GlobalData, Phase...